Cladribine and venetoclax combined with alemtuzumab in patients with relapsed/refractory T-cell prolymphocytic leukemia
作者
Naszrin Arani,Caitlin R. Rausch,Alexis Geppner,Gautam Borthakur,Nitin B. Jain,Alessandra Ferrajoli,Elias Jabbour,Deepa Sampath,Chitra Hosing,Francisco Vega,Hagop M. Kantarjian,Tapan M. Kadia